Success Metrics

Clinical Success Rate
90.6%

Based on 48 completed trials

Completion Rate
91%(48/53)
Active Trials
1(2%)
Results Posted
58%(28 trials)
Terminated
5(9%)

Phase Distribution

Ph phase_4
16
29%
Ph phase_2
6
11%
Ph not_applicable
3
5%
Ph phase_3
23
41%
Ph phase_1
5
9%

Phase Distribution

5

Early Stage

6

Mid Stage

39

Late Stage

Phase Distribution53 total trials
Phase 1Safety & dosage
5(9.4%)
Phase 2Efficacy & side effects
6(11.3%)
Phase 3Large-scale testing
23(43.4%)
Phase 4Post-market surveillance
16(30.2%)
N/ANon-phased studies
3(5.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

88.9%

48 of 54 finished

Non-Completion Rate

11.1%

6 ended early

Currently Active

1

trials recruiting

Total Trials

56

all time

Status Distribution
Active(1)
Completed(48)
Terminated(6)
Other(1)

Detailed Status

Completed48
Terminated5
Recruiting1
Withdrawn1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
56
Active
1
Success Rate
90.6%
Most Advanced
Phase 4

Trials by Phase

Phase 15 (9.4%)
Phase 26 (11.3%)
Phase 323 (43.4%)
Phase 416 (30.2%)
N/A3 (5.7%)

Trials by Status

recruiting12%
withdrawn12%
completed4886%
terminated59%
unknown12%

Recent Activity

Clinical Trials (56)

Showing 20 of 56 trialsScroll for more
NCT04922333Phase 3

Bisphosphonate Use to Mitigate Bone Loss Secondary to Bariatric Surgery

Recruiting
NCT02186600Phase 3

Heartland Osteoporosis Prevention Study

Completed
NCT04879420

Replication of the VERO Osteoporosis Trial in Healthcare Claims Data

Completed
NCT03861091Phase 2

Prophylactic Risedronate for Patients With Peripheral Lung Tumors Treated With SBRT

Completed
NCT00594334Phase 4

Effect of Actonel on Periodontal Health of Postmenopausal Women

Withdrawn
NCT05346419Not Applicable

Antiresorptive Effect of Treatment With Risedronate and Vitamin D in Postmenopausal Patients

Completed
NCT01077817

Observational Study of Incidence Rates of Esophageal Cancer in Women Taking Medications for the Prevention or Treatment of Osteoporosis (MK-0217A-352)

Completed
NCT00445575Phase 2

Effect of Risedronate on Bone Morbidity in Fibrous Dysplasia of Bone

Completed
NCT01950169Not Applicable

Effects of Bisphosphonates and Nutritional Supplementation After a Hip Fracture

Completed
NCT01406444Not Applicable

IGF-1 and Bone Loss in Women With Anorexia Nervosa

Completed
NCT00887354Phase 4

A Study That Will Compare the Effect of Two Drugs on Participants With Low Bone Mass and a Recent Hip Fracture

Completed
NCT01709110Phase 4

VERtebral Fracture Treatment Comparisons in Osteoporotic Women

Completed
NCT01675297Phase 4

Efficacy and Safety Study of Risedronate, Cholecalciferol Combination Tablet in Patients With Osteoporosis

Completed
NCT00266708Phase 1

Randomized Trial of Risedronate to Prevent Bone Loss in Renal Transplant Recipients.

Completed
NCT02744482Phase 3

Efficacy of Risedronate in Patients With Painful Periprosthetic Resorption of the Hip Prothesis

Terminated
NCT00859027Phase 4

Effect Of Risedronate On Bone Mass In Older Men Receiving Neoadjuvant Therapy For Prostate Cancer

Completed
NCT00666627Phase 2

Bisphosphonate Action on the Appendicular Skeleton: Evidence for Differential Effects

Completed
NCT00485953Phase 4

Effect of Bisphosphonate on Bone Loss in Postmenopausal Women With Breast Cancer Initiating Aromatase Inhibitor Therapy

Completed
NCT02148848Phase 4

Short-term Functional Recovery Between Early- and Late Bisphosphonate Treatment Following Hemiarthroplasty

Unknown
NCT00377234Phase 4

A Study Comparing Monthly Boniva (Ibandronate) and Weekly Risedronate in Women With Post-Menopausal Osteoporosis.

Completed

Drug Details

Intervention Type
DRUG
Total Trials
56